EDN1 and diabetes mellitus: ET-1 and its receptors mediate pathophysiological processes, such as inflammation, oxidative stress, endothelial dysfunction, and insulin resistance, leading to the occurrence and progression of diabetes and atherosclerotic diseases (11).